세계의 만성 폐쇄성 폐질환(COPD) 가상현실 치료 시장 보고서(2025년)

Chronic obstructive pulmonary disease (COPD) virtual reality therapy is a non-pharmacological treatment approach that uses immersive virtual reality environments to support respiratory rehabilitation, enhance lung function, and increase patient engagement. It combines interactive exercises, breathing techniques, and real-time feedback to help patients manage symptoms and improve overall quality of life. This therapy is increasingly integrated into digital health solutions for home-based and clinical pulmonary care.

The primary components of COPD virtual reality therapy include hardware, software, and services. Hardware refers to virtual reality headsets, sensors, wearables, and related devices used to deliver immersive, interactive therapies for pulmonary rehabilitation, breathing exercises, and symptom management in COPD patients. Therapy types include immersive and non-immersive virtual reality approaches. Applications cover pulmonary rehabilitation, patient education, pain management, anxiety and stress reduction, and other areas. Key end users include hospitals, clinics, home care settings, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The chronic obstructive pulmonary disease virtual reality therapy market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease virtual reality therapy market statistics, including the chronic obstructive pulmonary disease virtual reality therapy industry global market size, regional shares, competitors with the chronic obstructive pulmonary disease virtual reality therapy market share, detailed chronic obstructive pulmonary disease virtual reality therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease virtual reality therapy industry. This chronic obstructive pulmonary disease virtual reality therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic obstructive pulmonary disease virtual reality therapy market size has grown rapidly in recent years. It will grow from $1.15 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 19.7%. The growth during the historic period is linked to the increasing prevalence of chronic obstructive pulmonary disease (COPD), growing demand for non-pharmacological interventions, rising adoption of digital health solutions, need for cost-effective rehabilitation options, and greater awareness of the benefits of remote therapy.

The chronic obstructive pulmonary disease virtual reality therapy market size is expected to see rapid growth in the next few years. It will grow to $2.80 billion in 2029 at a compound annual growth rate (CAGR) of 19.3%. The growth projected for the forecast period is driven by increasing adoption of home-based rehabilitation, expanding healthcare digitization and telemedicine, rising healthcare expenditure in emerging markets, supportive reimbursement policies for digital therapeutics, and greater focus on reducing hospital readmissions. Primary trends during the forecast period include integration of virtual reality (VR) with artificial intelligence for personalized therapy, use of cloud-based platforms for remote pulmonary rehabilitation, incorporation of haptic feedback for immersive breathing exercises, adoption of digital twins for respiratory health simulation, and integration with wearable sensors for real-time monitoring.

Growing awareness and acceptance of virtual reality therapy are expected to drive growth in the chronic obstructive pulmonary disease virtual reality therapy market. Virtual reality therapy uses immersive technology to create interactive environments for treatment and rehabilitation. The increasing recognition of this therapy stems from its ability to reduce pain and anxiety, providing patients with a non-invasive, drug-free option that enhances treatment experiences and results. Awareness boosts adoption by educating patients and providers, encouraging the use of digital rehabilitation solutions. It also improves engagement by familiarizing users with immersive therapy, resulting in better adherence and health outcomes. For example, in July 2024, the U.S. Department of Veterans Affairs reported that approximately 3,500 virtual reality headsets were deployed across over 170 VA medical centers and outpatient clinics, tripling the number available for therapeutic purposes. This rise in awareness and acceptance is fueling the growth of the COPD virtual reality therapy market.

The growing focus on personalized medicine is also expected to support expansion of the chronic obstructive pulmonary disease virtual reality therapy market. Personalized medicine customizes treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environment. Advances in genomics have made it possible to identify genetic variations precisely and provide tailored treatments. Personalized medicine enhances COPD virtual reality therapy by adapting immersive rehabilitation programs to meet each patient's specific needs, increasing treatment effectiveness and focus. It improves outcomes by addressing unique symptoms, abilities, and preferences, which strengthens patient engagement and adherence. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a notable rise from 12 approvals in 2022. This growing emphasis on personalized medicine is propelling the COPD virtual reality therapy market forward.

In March 2025, Wellinks Inc., a digital healthcare company based in the United States, formed a partnership with CareAbout Health to broaden virtual-first COPD management programs within value-based care networks. This collaboration seeks to improve patient outcomes, lower hospitalization rates, and increase access to comprehensive home pulmonary care. CareAbout Health is a healthcare management company in the U.S. that supports virtual COPD care initiatives.

Major players in the chronic obstructive pulmonary disease virtual reality therapy market are Inova Health System, Rush University Medical Center, Penumbra Inc., Burke Rehabilitation Hospital, MindMaze SA, XRHealth Inc., Jolly Good Inc., AppliedVR Inc., Carda Health Inc., Lincare Inc., Virtually Better Inc., Wellinks Inc., Breathe Better Rehab, Kivo Health Inc., and VRelax B.V.

North America was the largest region in the chronic obstructive pulmonary disease virtual reality therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic obstructive pulmonary disease virtual reality therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic obstructive pulmonary disease virtual reality therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic obstructive pulmonary disease virtual reality therapy market consists of revenues earned by entities by providing services such as virtual pulmonary rehabilitation programs, guided breathing and relaxation sessions, remote respiratory therapy, patient education and training modules, tele-rehabilitation support, gamified exercise sessions, and social interaction platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic obstructive pulmonary disease virtual reality therapy market also includes sales of virtual reality (VR) headsets, motion controllers, haptic feedback devices, specialized respiratory training software, cloud-based therapy platforms, and virtual reality (VR)-enabled monitoring systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic obstructive pulmonary disease virtual reality therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic obstructive pulmonary disease virtual reality therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic obstructive pulmonary disease virtual reality therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Therapy Type: Immersive Virtual Reality Therapy; Non-Immersive Virtual Reality Therapy
• 3) By Application: Pulmonary Rehabilitation; Patient Education; Pain Management; Anxiety And Stress Reduction; Other Applications
• 4) By End-User: Hospitals; Clinics; Homecare Settings; Other End-Users
• Subsegments:
• 1) By Hardware: Virtual Reality Headsets; Motion Sensors; Haptic Feedback Devices; Wearable Monitors
• 2) By Software: Pulmonary Rehabilitation Applications; Patient Monitoring Platforms; Data Analytics Tools; Therapy Gamification Software
• 3) By Services: Remote Pulmonary Therapy; Technical Support; Training And Education; System Integration
• Companies Mentioned: Inova Health System; Rush University Medical Center; Penumbra Inc.; Burke Rehabilitation Hospital; MindMaze SA; XRHealth Inc.; Jolly Good Inc.; AppliedVR Inc.; Carda Health Inc.; Lincare Inc.; Virtually Better Inc.; Wellinks Inc.; Breathe Better Rehab; Kivo Health Inc.; VRelax B.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Characteristics

3. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Trends And Strategies

4. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Growth Rate Analysis
• 5.4. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Total Addressable Market (TAM)

6. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Segmentation

• 6.1. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immersive Virtual Reality Therapy
• Non-Immersive Virtual Reality Therapy
• 6.3. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Rehabilitation
• Patient Education
• Pain Management
• Anxiety And Stress Reduction
• Other Applications
• 6.4. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• Other End-Users
• 6.5. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virtual Reality Headsets
• Motion Sensors
• Haptic Feedback Devices
• Wearable Monitors
• 6.6. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Rehabilitation Applications
• Patient Monitoring Platforms
• Data Analytics Tools
• Therapy Gamification Software
• 6.7. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Remote Pulmonary Therapy
• Technical Support
• Training And Education
• System Integration

7. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Regional And Country Analysis

• 7.1. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 8.1. Asia-Pacific Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 9.1. China Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 9.2. China Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 10.1. India Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 11.1. Japan Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 11.2. Japan Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 12.1. Australia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 13.1. Indonesia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 14.1. South Korea Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 14.2. South Korea Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 15.1. Western Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 15.2. Western Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 16.1. UK Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 17.1. Germany Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 18.1. France Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 19.1. Italy Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 20.1. Spain Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 21.1. Eastern Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 21.2. Eastern Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 22.1. Russia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 23.1. North America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 23.2. North America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 24.1. USA Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 24.2. USA Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 25.1. Canada Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 25.2. Canada Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 26.1. South America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 26.2. South America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 27.1. Brazil Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 28.1. Middle East Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 28.2. Middle East Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

• 29.1. Africa Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Overview
• 29.2. Africa Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Competitive Landscape And Company Profiles

• 30.1. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Competitive Landscape
• 30.2. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Company Profiles
  • 30.2.1. Rush University Medical Center Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Penumbra Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Burke Rehabilitation Hospital Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. MindMaze SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. XRHealth Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Other Major And Innovative Companies

• 31.1. Jolly Good Inc.
• 31.2. AppliedVR Inc.
• 31.3. Carda Health Inc.
• 31.4. Lincare Inc.
• 31.5. Virtually Better Inc.
• 31.6. Wellinks Inc.
• 31.7. Breathe Better Rehab
• 31.8. Kivo Health Inc.
• 31.9. VRelax B.V.

32. Global Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

34. Recent Developments In The Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market

35. Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Obstructive Pulmonary Disease Virtual Reality Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer